Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Tobramycin 80mg/2ml solution for infusion ampoules
0501040U0AAAFAF
|
Tobramycin (Systemic) | Tobramycin | Infections | No data available |
|
Tobravisc 3mg/ml eye drops
1103010X0BCAAAA
|
Tobravisc | Tobramycin | Eye | No data available |
|
Tocilizumab 162mg/0.9ml inj pre-filled disposable devices
1001030W0AAAEAE
|
Tocilizumab | Tocilizumab | Musculoskeletal and Joint Diseases | No data available |
|
Tocilizumab 162mg/0.9ml inj pre-filled syringes
1001030W0AAADAD
|
Tocilizumab | Tocilizumab | Musculoskeletal and Joint Diseases | No data available |
|
Tocilizumab 80mg/4ml solution for infusion vials
1001030W0AAAAAA
|
Tocilizumab | Tocilizumab | Musculoskeletal and Joint Diseases | No data available |
|
ToddlerD Vitamin D3 200units oral spray
0906040G0EGAAFE
|
ToddlerD | Colecalciferol | Nutrition and Blood | No data available |
|
Toepedo cream
1310020V0BEAAAD
|
Toepedo | Salicylic acid | Skin | No data available |
|
Tofacitinib 10mg tablets
1001030ABAAACAC
|
Tofacitinib | Tofacitinib | Musculoskeletal and Joint Diseases | No data available |
|
Tofacitinib 11mg modified-release tablets
1001030ABAAADAD
|
Tofacitinib | Tofacitinib | Musculoskeletal and Joint Diseases | No data available |
|
Tofranil 25mg tablets
0403010N0BCABAE
|
Tofranil | Imipramine hydrochloride | Central Nervous System | No data available |
|
Tofranil 25mg/5ml syrup
0403010N0BCACAC
|
Tofranil | Imipramine hydrochloride | Central Nervous System | No data available |
|
Tolbutamide 1g/5ml oral suspension
0601021X0AAALAL
|
Tolbutamide | Tolbutamide | Endocrine System | No data available |
|
Tolbutamide 250mg/5ml oral suspension
0601021X0AAAKAK
|
Tolbutamide | Tolbutamide | Endocrine System | No data available |
|
Tolbutamide 500mg/5ml oral suspension
0601021X0AAAJAJ
|
Tolbutamide | Tolbutamide | Endocrine System | No data available |
|
Tolnaftate 0.12% spray
1310020Y0AAAKAK
|
Tolnaftate | Tolnaftate | Skin | No data available |
|
Tolnaftate 1% / Benzalkonium chloride 0.1% cream
1310020Y0AAALAL
|
Tolnaftate | Tolnaftate | Skin | No data available |
|
Tolnaftate 1% / Benzalkonium chloride 0.1% ointment
1310020Y0AAAGAG
|
Tolnaftate | Tolnaftate | Skin | No data available |
|
Tolnaftate 1% / Chlorhexidine 0.25% powder
1310020Y0AAAHAH
|
Tolnaftate | Tolnaftate | Skin | No data available |
|
Tolnaftate 1% cream
1310020Y0AAAAAA
|
Tolnaftate | Tolnaftate | Skin | No data available |
|
Tolnaftate 1% dry powder spray
1310020Y0AAAJAJ
|
Tolnaftate | Tolnaftate | Skin | No data available |
|
Tolterodine 1mg/5ml oral liquid
0704020N0AAAHAH
|
Tolterodine | Tolterodine | Obstetrics, Gynaecology and Urinary-Tract Disorders | No data available |
|
Tolterodine 2mg oral powder sachets
0704020N0AAAFAF
|
Tolterodine | Tolterodine | Obstetrics, Gynaecology and Urinary-Tract Disorders | No data available |
|
Tolterodine 2mg/5ml oral solution
0704020N0AAAEAE
|
Tolterodine | Tolterodine | Obstetrics, Gynaecology and Urinary-Tract Disorders | No data available |
|
Tolterodine 4mg/5ml oral liquid
0704020N0AAAGAG
|
Tolterodine | Tolterodine | Obstetrics, Gynaecology and Urinary-Tract Disorders | No data available |
|
Tolucombi 40mg/12.5mg tablets
0205052R0BDAAAA
|
Tolucombi | Telmisartan with diuretic | Cardiovascular System | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.